IP Verse

Roche vs. Tandem Diabetes Care - UPC_CFI_11/2025

The case UPC_CFI_11/2025 was filed by the plaintiff Roche Diabetes Care against the defendant Tandem Diabetes Care on 20 Jan, 2025.

Case Timeline

20 Jan, 2025
Case Filed
29 Jan, 2025
Interim Conference
Today Nov 1, 2025
Oral Procedure
Decision

Case Details

    Case Number:

    UPC_CFI_11/2025

    Patent Number:

    EP2196231

    Filing Date:

    20 Jan, 2025

    Proceeding Type:

    Generic

    Case Phase:

    Case Closed

    Plaintiffs:

    • Roche Diabetes Care

    Plaintiff Representative:

    • Christof Augenstein

    Defendants:

    • Tandem Diabetes Care
    • Tandem Diabetes Care Europe

    Defendant Representative:

    • Christian Dekoninck

    Judges:

    • Giorgio Checcacci
    • Paolo Catallozzi
    • Tatyana Zhilova

    Court Division:

    First Instance, Central Division - Paris

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

Apr 30, 2025Final Order App For A Cost Decision 831 25
Apr 30, 2025Final Order 831 25 Anonymized
Apr 29, 2025Headnote And Keywords
Apr 29, 2025Cost Decision
Apr 29, 2025Application For Costs Decision Outcome
Mar 21, 2025Comments Cost Application
Mar 10, 2025Final Order Anonymized 06.03
Mar 6, 2025Rule 262A
Mar 6, 2025Preliminary Order
Mar 4, 2025Submission Roche
Mar 4, 2025Exhibit Kap Kfa 19 Redacted
Mar 4, 2025Exhibit Kap Kfa 19 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 18 Redacted
Mar 4, 2025Exhibit Kap Kfa 18 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 17 Redacted
Mar 4, 2025Exhibit Kap Kfa 17 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 16 Redacted
Mar 4, 2025Exhibit Kap Kfa 16 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 15 Redacted
Mar 4, 2025Exhibit Kap Kfa 15 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 14 Redacted
Mar 4, 2025Exhibit Kap Kfa 14 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 13 Redacted
Mar 4, 2025Exhibit Kap Kfa 13 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 12 Redacted
Mar 4, 2025Exhibit Kap Kfa 12 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 11 Redacted
Mar 4, 2025Exhibit Kap Kfa 11 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 10 Redacted
Mar 4, 2025Exhibit Kap Kfa 10 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 09 Redacted
Mar 4, 2025Exhibit Kap Kfa 09 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 08 Redacted
Mar 4, 2025Exhibit Kap Kfa 08 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 07 Redacted
Mar 4, 2025Exhibit Kap Kfa 07 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 06 Redacted
Mar 4, 2025Exhibit Kap Kfa 06 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 05 Redacted
Mar 4, 2025Exhibit Kap Kfa 05 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 04 Redacted
Mar 4, 2025Exhibit Kap Kfa 04 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 03 Redacted
Mar 4, 2025Exhibit Kap Kfa 03 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 02 Redacted
Mar 4, 2025Exhibit Kap Kfa 02 En Strictly Confidential Unredacted
Mar 4, 2025Exhibit Kap Kfa 01 Redacted
Mar 4, 2025Exhibit Kap Kfa 01 En Strictly Confidential Unredacted
Mar 4, 2025Application For A Cost Decision Roche Redacted
Feb 26, 2025Preliminary Order Anonymized
Feb 25, 2025Rule 262 (A)
Feb 25, 2025Outcome Of The Order
Feb 13, 2025Response To Order Of The Court Comments To Application Pursuant To Rule 262A
Feb 3, 2025Exhibit Kap Kfa 19 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 18 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 17 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 16 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 15 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 14 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 13 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 12 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 11 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 10 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 09 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 08 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 07 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 06 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 05 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 04 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 03 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 02 En Strictly Confidential
Feb 3, 2025Exhibit Kap Kfa 01 En Strictly Confidential
Feb 3, 2025Brief Roche Regarding Submission Confidential Documents Signed
Feb 3, 2025Application For A Cost Decision Roche Strictly Confidential
Jan 29, 2025Rule 262 (A)
Jan 29, 2025Preliminary Order Anonymized 29.01
Jan 20, 2025Receipt
Jan 20, 2025Panel Appointment
Jan 20, 2025Exhibit Kap Kfa 25 De
Jan 20, 2025Exhibit Kap Kfa 24 De
Jan 20, 2025Exhibit Kap Kfa 23 De
Jan 20, 2025Exhibit Kap Kfa 22 De
Jan 20, 2025Exhibit Kap Kfa 21 En
Jan 20, 2025Exhibit Kap Kfa 20 De
Jan 20, 2025Exhibit Kap Kfa 19 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 18 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 17 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 16 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 15 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 14 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 13 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 12 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 11 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 10 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 09 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 08 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 07 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 06 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 05 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 04 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 03 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 02 En Strictly Confidential
Jan 20, 2025Exhibit Kap Kfa 01 En Strictly Confidential
Jan 20, 2025Application For Confidentiality R 262A Signed
Jan 20, 2025Application For Confidentiality R 262 2 Signed
Jan 20, 2025Application For A Cost Decision Roche Strictly Confidential Signed
Jan 20, 2025Acknowledgement Of Lodging

More cases involving EP2196231B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_7604/2025Feb 17, 2025Tandem Diabetes Care, Tandem Diabetes Care EuropeRoche
UPC_COA_120/2025Feb 17, 2025Tandem Diabetes Care, Tandem Diabetes Care EuropeRoche
CC_36199/2024Jun 17, 2024VitalaireF Hoffmann LA Roche, Roche

More cases involving Roche

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
ACT_34241/2025Aug 7, 2025F Hoffmann LA Roche, RocheAmenarini Diagnostics, Amenarini Diagnostics France Sasu, Berlin Chemie
UPC_CFI_712/2025Aug 7, 2025F Hoffmann LA RocheAmenarini Diagnostics, Amenarini Diagnostics France Sasu, Berlin Chemie
APP_29093/2025Jun 19, 2025F Hoffman LA Roche, Roche -

More cases involving Tandem Diabetes Care

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_30135/2025Jun 27, 2025Tandem Diabetes Care, Tandem Diabetes Care Europe -
APP_30138/2025Jun 26, 2025Tandem Diabetes Care, Tandem Diabetes Care Europe -
ORD_27832/2025Jun 11, 2025F Hoffman LA Roche, RocheTandem Diabetes Care, Tandem Diabetes Care Europe